{"id":"https://openalex.org/W2491380282","doi":"https://doi.org/10.1158/1538-7445.am2016-356","title":"Abstract 356: Development and characterization of an in vitro co-culture angiogenesis assay system using hTERT immortalized cells for high throughput drug screening","display_name":"Abstract 356: Development and characterization of an in vitro co-culture angiogenesis assay system using hTERT immortalized cells for high throughput drug screening","publication_year":2016,"publication_date":"2016-07-15","ids":{"openalex":"https://openalex.org/W2491380282","doi":"https://doi.org/10.1158/1538-7445.am2016-356","mag":"2491380282"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2016-356","doi":"https://doi.org/10.1158/1538-7445.am2016-356","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-356","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113569228","display_name":"Chaozhong Zou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chaozhong Zou","raw_affiliation_strings":["1ATCC, Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ATCC, Gaithersburg, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112388980","display_name":"Chia-Wen Hsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chia-Wen Hsu","raw_affiliation_strings":["2Division for Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division for Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060481078","display_name":"Chengkang Zhang","orcid":"https://orcid.org/0000-0002-3746-2095","observed_orcids":["https://orcid.org/0000-0002-3746-2095"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chengkang Zhang","raw_affiliation_strings":["1ATCC, Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ATCC, Gaithersburg, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038309212","display_name":"Isabela Batista Oliva","orcid":"https://orcid.org/0009-0008-2328-062X","observed_orcids":["https://orcid.org/0009-0008-2328-062X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isabela Oliva","raw_affiliation_strings":["1ATCC, Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ATCC, Gaithersburg, MD;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002770603","display_name":"Metewo Selase Enuameh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Metewo S. Enuameh","raw_affiliation_strings":["1ATCC, Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ATCC, Gaithersburg, MD;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"14_Supplement","first_page":"356","last_page":"356"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiogenesis-assay","display_name":"angiogenesis assay","score":0.8859999775886536},{"id":"https://openalex.org/keywords/in-vitro-angiogenesis-model","display_name":"in vitro angiogenesis model","score":0.6850000023841858},{"id":"https://openalex.org/keywords/human-aortic-endothelial-cells","display_name":"human aortic endothelial cells","score":0.8679999709129333},{"id":"https://openalex.org/keywords/adipose-derived-stem-cells","display_name":"adipose-derived stem cells","score":0.9860000014305115},{"id":"https://openalex.org/keywords/tubule-formation","display_name":"tubule formation","score":0.7519999742507935},{"id":"https://openalex.org/keywords/vegf-signaling-pathway","display_name":"VEGF pathway","score":0.7850000262260437},{"id":"https://openalex.org/keywords/high-throughput-drug-screening","display_name":"high-throughput drug screening","score":0.8270000219345093},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.8140000104904175},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.890999972820282},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/ramucirumab","display_name":"ramucirumab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/hif-1-inhibitors","display_name":"HIF-1 inhibitors","score":0.9850000143051147}],"concepts":[{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.8191187381744385},{"id":"https://openalex.org/C125593758","wikidata":"https://www.wikidata.org/wiki/Q15315135","display_name":"Telomerase reverse transcriptase","level":4,"score":0.8114078044891357},{"id":"https://openalex.org/C2778608917","wikidata":"https://www.wikidata.org/wiki/Q6787805","display_name":"Matrigel","level":3,"score":0.7618939876556396},{"id":"https://openalex.org/C6045943","wikidata":"https://www.wikidata.org/wiki/Q21014462","display_name":"Immortalised cell line","level":3,"score":0.6544344425201416},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.6412784457206726},{"id":"https://openalex.org/C198826908","wikidata":"https://www.wikidata.org/wiki/Q1922379","display_name":"Mesenchymal stem cell","level":2,"score":0.48950397968292236},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.47823113203048706},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.451094388961792},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4270326495170593},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3777063190937042},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37742099165916443},{"id":"https://openalex.org/C94581717","wikidata":"https://www.wikidata.org/wiki/Q331839","display_name":"Telomerase","level":3,"score":0.32122665643692017},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14703592658042908},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10272863507270813},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2016-356","doi":"https://doi.org/10.1158/1538-7445.am2016-356","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-356","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2739728953","https://openalex.org/W2885370092","https://openalex.org/W2755841503","https://openalex.org/W4301250561","https://openalex.org/W1561178184","https://openalex.org/W1600721209","https://openalex.org/W2141171507","https://openalex.org/W2411670590","https://openalex.org/W2602668770","https://openalex.org/W2126612804"],"abstract_inverted_index":{"Abstract":[0],"Angiogenesis":[1],"is":[2,8,35,240],"a":[3,11,108,118,358],"multi-step":[4],"physiological":[5,201],"process":[6],"which":[7,34,177,257,290,308],"involved":[9],"in":[10,43,82,117,166,172,354,362,392],"large":[12],"number":[13],"of":[14,33,38,88,93,154,193,225,232,256,277,280,321,390,410,415],"normal":[15],"and":[16,50,67,107,141,171,227,252,360,371,388],"disease":[17],"state":[18],"processes;":[19],"In":[20,76],"vitro":[21,83,363,393],"angiogenesis":[22,218,395],"models":[23,60,346],"provide":[24,357],"very":[25],"useful":[26],"tools":[27],"to":[28,71,73,222,229],"study":[29],"these":[30],"processes,":[31],"one":[32],"the":[36,123,147,150,174,179,198,206,217,236,259,266,275,281,285,293,299,319,322,344,411,416],"analysis":[37],"tubule":[39],"formation.":[40],"Tubules":[41],"formed":[42],"co-culture":[44,59,84,160,267,345,394],"assays":[45],"were":[46,132],"significantly":[47],"more":[48,51,234],"heterogeneous":[49],"closely":[52],"resembled":[53],"capillaries":[54],"than":[55,168],"Matrigel\u00ae":[56],"tubules.":[57],"Current":[58],"using":[61,349,398],"primary":[62],"cells":[63,148,176,401],"have":[64,142,182,309],"donor":[65],"variability,":[66],"inconsistent":[68],"results":[69,214,264,320],"due":[70],"lot":[72,74],"variation.":[75],"this":[77,355],"study,":[78],"we":[79,204,297],"established":[80],"an":[81,89,94,391],"model":[85],"system":[86,161,199,208,219,268,283,301,324,333,364,397],"consisting":[87],"assay":[90,396],"ready":[91],"mixture":[92],"aortic":[95,103],"endothelial":[96,104],"cell":[97,105,114,130,351],"line":[98,115],"TeloHAEC-GFP":[99],"(hTERT":[100],"immortalized":[101,110,133,400],"human":[102],"line)":[106],"hTERT":[109,135,399],"adipose-derived":[111],"mesenchymal":[112],"stem":[113],"hTERT-MSC":[116,175],"common":[119],"specially":[120],"formulated":[121],"medium,":[122],"AngioReady\u2122angiogenesis":[124],"medium":[125],"with":[126,209,284,326],"VEGF":[127,226,260,294],"supplement.":[128],"Both":[129],"lines":[131,352],"by":[134,186,244,274,313,348],"(human":[136],"telomerase":[137],"reverse":[138],"transcriptase)":[139],"alone":[140],"been":[143],"well-characterized":[144],"showing":[145],"that":[146,197,211,216],"retain":[149],"most":[151],"important":[152],"characteristic":[153],"their":[155],"parental":[156],"counterparts.":[157],"The":[158],"new":[159,207,323],"forms":[162],"functional":[163],"tubular":[164,180,237],"structures":[165,181],"less":[167],"7":[169],"days,":[170],"addition,":[173],"surround":[178],"undergone":[183],"transformation":[184],"indicated":[185,273],"elevated":[187,223],"positive":[188],"\u03b1SMA":[189],"staining":[190],"(a":[191],"marker":[192],"smooth":[194],"muscle":[195],"cells),indicating":[196],"has":[200,269],"relevance.":[202],"Next,":[203],"tested":[205],"compounds":[210],"impact":[212],"angiogenesis,":[213],"demonstrated":[215],"responds":[220],"positively":[221],"doses":[224],"negatively":[228],"increasing":[230],"concentrations":[231],"suramin;":[233],"importantly,":[235],"formation":[238],"efficiency":[239],"reduced":[241],"or":[242],"blocked":[243],"well-known":[245],"cancer":[246,286],"drugs":[247],"such":[248],"as":[249,338,340],"Sunitinib":[250],"(SUTENT\u00ae)":[251],"Bevacizumab":[253],"(Avastin\u00ae),":[254],"both":[255],"target":[258],"pathway.":[261,295],"Notably,":[262],"our":[263],"showed":[265,318],"minimal":[270],"lot-to-lot":[271],"variation":[272],"treatment":[276],"three":[278],"lots":[279],"Angio-ready\u2122":[282,300,332],"drug,":[287],"Ramucirumab":[288],"(Cyramza\u00ae),":[289],"also":[291],"targets":[292],"Finally,":[296],"used":[298],"validated":[302],"4":[303],"HIF-1(hypoxia":[304],"inducible":[305],"factors-1)":[306],"inhibitors":[307],"anti-angiogenic":[310],"properties":[311],"identified":[312],"high-throughput":[314],"screening":[315,328,334,370],"methods;":[316],"data":[317],"match":[325],"other":[327],"methods,":[329],"what's":[330],"more,":[331],"time":[335],"can":[336],"be":[337],"short":[339],"3":[341],"days.":[342],"Therefore,":[343],"developed":[347],"hTERT-immortalized":[350],"described":[353],"report":[356],"consistent":[359],"robust":[361],"for":[365,402,419],"studying":[366],"cardiovascular":[367],"biology,":[368],"drug":[369,405],"tissue":[372],"engineering.":[373],"Citation":[374],"Format:":[375],"Chaozhong":[376],"Zou,":[377],"Chia-Wen":[378],"Hsu,":[379],"Chengkang":[380],"Zhang,":[381],"Isabela":[382],"Oliva,":[383],"Metewo":[384],"S.":[385],"Enuameh.":[386],"Development":[387],"characterization":[389],"high":[403],"throughput":[404],"screening.":[406],"[abstract].":[407],"In:":[408],"Proceedings":[409],"107th":[412],"Annual":[413],"Meeting":[414],"American":[417],"Association":[418],"Cancer":[420,431],"Research;":[421],"2016":[422],"Apr":[423],"16-20;":[424],"New":[425],"Orleans,":[426],"LA.":[427],"Philadelphia":[428],"(PA):":[429],"AACR;":[430],"Res":[432],"2016;76(14":[433],"Suppl):Abstract":[434],"nr":[435],"356.":[436]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2016-08-23T00:00:00"}